泰邦生物集团有限公司

About 泰邦生物集团有限公司

Founded in 2002, Taibang Biological Group is a leading integrated biopharmaceutical enterprise in China, with core businesses including the research and development, production, and sales of blood products and biological products. As a leader in the blood products industry, Taibang Biological Group possesses the largest-scale blood product manufacturing base in Asia with international leading technology; it has an industry-leading R&D team and advanced blood product R&D laboratories; it has a product line covering albumin, immunoglobulin, and clotting factors, with over 20 specifications. In addition, the group's non-blood product business segment has multiple product lines including artificial dura mater, artificial spinal dura, artificial nerve conduits, and fascia lata, as well as a full range of neurosurgical products from the German brand Zeppelin. Its products cover the medical market in all provinces, cities, autonomous regions, and municipalities in mainland China. With the mission of "making good medicine for human health," Taibang people focus on serving patient needs, continuously setting industry standards, and carrying a high sense of responsibility and mission in the R&D and production of every product. Looking ahead, Taibang Group will continue to explore in the field of biopharmaceuticals, strive continuously, and pursue relentlessly. It will accelerate the pace of R&D for new blood products and biopharmaceutical products, aiming to become a world-class biopharmaceutical enterprise.